/

Batteries & E-Mobility

/

Tanvex Biopharma USA, Inc

Tanvex Biopharma USA, Inc

Tanvex Biopharma USA, Inc

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

San Diego, California

·

Since 2011

Tanvex Biopharma USA is a contract development and manufacturing organization (CDMO) headquartered in San Diego, California, founded in 2011. The privately held company, with 50–100 employees and estimated revenue of $10–50 million, specializes in biosimilar development and GMP manufacturing for the pharmaceutical and biotech industries. Operating under the Bora Biologics brand, the company submitted regulatory documentation to the FDA in 2026 for a Herceptin biosimilar candidate.

Tanvex Biopharma USA, Inc

Verified Nov 2026

AT A GLANCE

Founded

2011

Headquarters

United States flag

San Diego, California

Employees

50-100

Ownership

Tanvex Biopharma USA, Inc at a glance

Revenue

$10-50M

Est. band

Employees

50-100

Founded

2011

Headquarters

San Diego, California

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Tanvex Biopharma USA is a contract development and manufacturing organization (CDMO) headquartered in San Diego, California, founded in 2011. The privately held company, with 50–100 employees and estimated revenue of $10–50 million, specializes in biosimilar development and GMP manufacturing for the pharmaceutical and biotech industries. Operating under the Bora Biologics brand, the company submitted regulatory documentation to the FDA in 2026 for a Herceptin biosimilar candidate.

At a glance

Attribute

Detail

Founded

2011

Headquarters

San Diego, California

Employees

50-100

Revenue

$10-50M (estimated)

Primary capability

Batteries & E-Mobility

What Tanvex Biopharma USA, Inc makes

The company provides analytical development, GMP manufacturing, upstream processing, cell culture, protein purification, and regulatory support services for biosimilar and biopharmaceutical programs.

Latest developments

Facilities

Tanvex Biopharma USA, Inc is headquartered in San Diego, California. Public sources also reference these locations:

Company details

Tanvex BioPharma USA received a capital injection approved by its parent company's board in December 2025, with an authorized increase of up to $45 million. Tanvex Biopharma USA, Inc was founded in 2011, has an estimated 50-100 employees, and is headquartered in San Diego, California.

Frequently asked questions

What does Tanvex Biopharma USA, Inc make?

Tanvex Biopharma USA is a contract development and manufacturing organization (CDMO) headquartered in San Diego, California, founded in 2011. The privately held company, with 50–100 employees and estimated revenue of $10–50 million, specializes in biosimilar development and GMP manufacturing for the pharmaceutical and biotech industries. Operating under the Bora Biologics brand, the company submitted regulatory documentation to the FDA in 2026 for a Herceptin biosimilar candidate.

Where is Tanvex Biopharma USA, Inc headquartered?

Tanvex Biopharma USA, Inc is headquartered in San Diego, California (10394 Pacific Center Ct, San Diego, California, 92121).

When was Tanvex Biopharma USA, Inc founded?

Tanvex Biopharma USA, Inc was founded in 2011.

How big is Tanvex Biopharma USA, Inc?

Tanvex Biopharma USA, Inc has an estimated 50-100 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

San Diego, California (HQ)Headquarters · United States
San Diego, California (HQ)10394 Pacific Center Ct, San Diego, California, 92121, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.